Jörg Faber

986 total citations
35 papers, 512 citations indexed

About

Jörg Faber is a scholar working on Pediatrics, Perinatology and Child Health, Sociology and Political Science and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jörg Faber has authored 35 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pediatrics, Perinatology and Child Health, 13 papers in Sociology and Political Science and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jörg Faber's work include Childhood Cancer Survivors' Quality of Life (19 papers), Family Support in Illness (13 papers) and Acute Lymphoblastic Leukemia research (7 papers). Jörg Faber is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (19 papers), Family Support in Illness (13 papers) and Acute Lymphoblastic Leukemia research (7 papers). Jörg Faber collaborates with scholars based in Germany, Italy and United Kingdom. Jörg Faber's co-authors include Philipp S. Wild, Manfred E. Beutel, Elmar Brähler, Mareike Ernst, Hiltrud Merzenich, H. J. Schmitt, Beate Schmöele-Thoma, Markus Knuf, Astrid Schneider and John de Wit and has published in prestigious journals such as Nature Communications, Scientific Reports and Social Science & Medicine.

In The Last Decade

Jörg Faber

32 papers receiving 496 citations

Peers

Countries citing papers authored by Jörg Faber

Since Specialization

Citations

This map shows the geographic impact of Jörg Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Faber more than expected).

Fields of papers citing papers by Jörg Faber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Faber. The network helps show where Jörg Faber may publish in the future.

Co-authorship network of co-authors of Jörg Faber

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Faber. A scholar is included among the top collaborators of Jörg Faber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Faber. Jörg Faber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation and implementation of multidisciplinary, standardized, guideline-based long-term follow-up care for adult survivors of childhood cancer in Germany: protocol of a prospective, multi-center, nationwide study (LE-Na) 2025 ·BMC Cancer ·(unknown), Katja Baust, Anja Borgmann‐Staudt, Gabriele Calaminus, (unknown), Jörg Faber, Desiree Grabow, Teresa Halbsguth, (unknown), Inke R. König, S. Michaelis, Anke Neumann, (unknown), Simon Schuster, Frank J. Wolters, Catherine Arendt, (unknown), Thorsten Langer, Judith Gebauer	0
2	The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial 2025 ·Nature Communications ·Jaume Mora, Gcf Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Jörg Faber, Arthur Wingerter, (unknown), (unknown), (unknown), Karen Tornøe, Maria Düring, Brian H. Kushner	3
3	Quality of life after pediatric cancer: comparison of long-term childhood cancer survivors’ quality of life with a representative general population sample and associations with physical health and risk indicators 2023 ·Health and Quality of Life Outcomes ·Mareike Ernst, Andreas Hinz, Elmar Brähler, Hiltrud Merzenich, Jörg Faber, Philipp S. Wild, Manfred E. Beutel	8
4	A Mixed-Methods Investigation of Medical Follow-Up in Long-Term Childhood Cancer Survivors: What Are the Reasons for Non-Attendance? 2022 ·Frontiers in Psychology ·Mareike Ernst, Elmar Brähler, Jörg Faber, Philipp S. Wild, Hiltrud Merzenich, Manfred E. Beutel	9
5	Development, validation, and application of an LC–MS/MS method for the quantification of the novel antibiotic drug lefamulin (Xenleta®) and its main metabolite 2R-hydroxy lefamulin in human plasma 2021 ·Journal of Pharmaceutical and Biomedical Analysis ·Dirk B Strickmann, Jörg Faber, Tobias Klaassen	3
6	Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients 2021 ·Supportive Care in Cancer ·(unknown), (unknown), Marie A. Neu, Nadine Lehmann, Khalifa El Malki, Claudia Paret, Niklas Joisten, Wilhelm Bloch, Philipp Zimmer, Jörg Faber	18
7	What's past is prologue: Recalled parenting styles are associated with childhood cancer survivors' mental health outcomes more than 25 years after diagnosis 2020 ·Social Science & Medicine ·Mareike Ernst, Elmar Brähler, Eva M. Klein, Claus Jünger, Philipp S. Wild, Jörg Faber, Astrid Schneider, Manfred E. Beutel	12
8	Loneliness predicts suicidal ideation and anxiety symptoms in long-term childhood cancer survivors 2020 ·International Journal of Clinical and Health Psychology ·Mareike Ernst, Elmar Brähler, Philipp S. Wild, Jörg Faber, Hiltrud Merzenich, Manfred E. Beutel	22
9	Central Venous Access Devices (CVAD) in Pediatric Oncology Patients—A Single-Center Retrospective Study Over More Than 9 Years 2019 ·Frontiers in Pediatrics ·Olaf Beck, Oliver J. Muensterer, Sarah Hofmann, Heidi Rossmann, Alicia Poplawski, Jörg Faber, (unknown)	29
10	Status and predictors of planning ability in adult long-term survivors of CNS tumors and other types of childhood cancer 2019 ·Scientific Reports ·Mareike Ernst, Ana N. Tibubos, Josef M. Unterrainer, Juliane Burghardt, Elmar Brähler, Philipp S. Wild, Claus Jünger, Jörg Faber, Astrid Schneider, Manfred E. Beutel	1
11	Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancer 2018 ·Clinical Research in Cardiology ·Marina Panova‐Noeva, Marie A. Neu, Susan Eckerle, Claudia Spix, Astrid Schneider, Irene Schmidtmann, Henri M.H. Spronk, Norbert Pfeiffer, Manfred E. Beutel, Karl J. Lackner, Thomas Münzel, Hugo Ten Cate, Hiltrud Merzenich, Jörg Faber, Philipp S. Wild	6
12	Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis? 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Tobias M. Dantonello, Christian Vokuhl, Monika Scheer, Monika Sparber‐Sauer, Sabine Stegmaier, Guido Seitz, Heike Scheithauer, Jörg Faber, (unknown), Peter Kaatsch, Stefan Bielack, Thomas Klingebiel, Ewa Kościelniak	4
13	MMR and MMRV vaccines 2017 ·Vaccine ·Frank Kowalzik, Jörg Faber, Markus Knuf	22
14	Erectile function after treatment for rhabdomyosarcoma of prostate and bladder 2016 ·Journal of Pediatric Urology ·Sebastian Frees, Peter Rubenwolf, (unknown), Jörg Faber, P. Gutjahr, (unknown), (unknown), Raimund Stein	9
15	Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·Eva Rettinger, Matthias Merker, Emilia Salzmann‐Manrique, Hermann Kreyenberg, (unknown), Matthias Dürken, Jörg Faber, Sabine Huenecke, (unknown), Melanie Bremm, André Willasch, Shahrzad Bakhtiar, Andrea Jarisch, Jan Soerensen, Thomas Klingebiel, Peter Bader	23
16	Ultrasound Evaluation of Thyroid Gland Pathologies After Radiation Therapy and Chemotherapy to Treat Malignancy During Childhood 2015 ·International Journal of Radiation OncologyBiologyPhysics ·André Lollert, (unknown), Katharina Laudemann, Jörg Faber, (unknown), J. König, Christoph Düber, Gundula Staatz	8
17	A combination vaccine against measles, mumps, rubella and varicella 2008 ·Drugs of today ·Markus Knuf, Jörg Faber, (unknown), Pirmin Habermehl	15
18	Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life 2006 ·Vaccine ·Markus Knuf, Pirmin Habermehl, Jörg Faber, H.L. Bock, Roland Sänger, H. Bogaerts, Ralf Clemens, Anne Schuind, (unknown), (unknown)	13
19	The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine 2003 ·Vaccine ·H. J. Schmitt, Jörg Faber, (unknown), Beate Schmöele-Thoma, (unknown)	58
20	Psychosocial Impact of Acne vulgaris 2001 ·Dermatology ·(unknown), V. Sigurdsson, Esther J van Zuuren, (unknown), Jörg Faber, John de Wit, W.A. van Vloten	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact